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 ABSTRACT
Pigeon circovirus infections occur in both young and adult racing and meat pigeons and have been reported worldwide. 
In the present study, the ORF C1 capsid gene of pigeon circovirus was expressed in insect cells and the expressed protein 
was used in an indirect immunofluorescence assay to determine antibody titres in naturally infected pigeons. The viral 
load of sera and the Bursa of Fabricius were also measured by real-time polymerase chain reaction. Twenty seven of the 
28 serum samples tested were found positive for antibodies to pigeon circovirus capsid protein (titres from log
2
 4 to log
2
 
8). The circovirus was detected in serum and Bursa of all young pigeons by real time polymerase chain reaction, but serum 
of all adult pigeons (1 year old or older) was negative. Viral loads in the serum (6.56 x 108 ± 8.18 x 108 copies genome/µl) 
and in the Bursa (4 x 1010 ± 3.87 x 1010 copies genome/milligram tissue) of sick young pigeons were significantly higher 
when compared to those in the serum (4.52 x 107 ± 1.35 x 108 copies genome/µl) and in the Bursa (6.64 x 109 ± 1.12 x 1010 
copies genome/milligram tissue) of clinically healthy pigeons. This suggests that the detection of high levels of virus may 
be associated with the clinical status of the birds.
ARTICLES
INTRODUCTION
Pigeon circovirus (PiCV) infection occurs in both racing and 
meat pigeons, and has been reported worldwide (1, 2, 3, 4, 5, 6, 
7, 8, 9, 10). This infection is common in pigeons aged between 1 
day and 6 months of age (11, 12). A broad range of clinical signs, 
including lethargy, weight loss, respiratory distress, diarrhea, poor 
racing performance and mortality are seen in infected pigeons. 
In racing pigeons this combination of clinical signs is commonly 
described as "young pigeon disease syndrome" (YPDS), with the 
type and severity of the clinical signs depending on the secondary 
pathogens present (13, 14). YPDS has clinico-pathological features 
in common with post-weaning multisystemic wasting syndrome 
(PMWS) with which porcine circovirus type 2 (PCV2) is associated. 
The apparent predisposition to secondary infections is suggestive of 
immunosuppression. While the primary effect of chicken anaemia 
virus (CAV), a Gyrovirus of the Circoviridae family, is depletion of 
the T cells in the thymus with minimal effect on the B cells in the 
Bursa of Fabricius, the PCV2 and PiCV appear to deplete both the B 
and T cells (15, 16). 
Initially, the diagnosis of the PiCV infection was mainly based on 
histology, sometimes confirmed by electron microscopy.  However 
the availability of cloned PiCV DNA and nucleotide sequence 
data has allowed the development of in situ hybridization, dot blot 
hybridization and polymerase chain reaction (PCR) assays (17, 
18, 19, 20, 21, 22), which can detect very small amounts of viral 
DNA. PiCV DNA can be found both in healthy and sick birds (20), 
in the absence of the microscopic observation of the characteristic 
botryoid inclusions which are pathognomonic for PiCV infection. 
Botryoid inclusions are found in lymphoreticular tissues. In 32 Bursa 
of Fabricius (BF) samples from normal and sick pigeons, these 
inclusions were observed in 41 % of samples whereas 84 % were 
found positive by PCR (20).  A real-time PCR assay based on SYBR 
Green chemistry, has been developed for the quantification of PiCV 
DNA in various samples (23). Testing of diseased pigeons showed 
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that the viral loads were high in BF (up to 2.07 x 109 copies/mg), 
liver (up to 2.88 x 108 copies/mg) and spleen (up to 5.57 x 108 copies/
mg).   In liver samples, the viral load was significantly higher in sick 
pigeons than in apparently healthy ones. This is also observed for 
PCV2 for which there is a strong correlation between high PCV2 
genomic load in tissues and PMWS (24). 
So far, there are no reports describing the isolation and propagation 
of PiCV in cell culture and there are no virus-specific antisera 
for detecting virus antigen. Recently, an indirect enzyme-linked 
immunosorbent assay for the detection PiCV-specific serum antibody 
was developed and may be a useful tool to PiCV diagnosis (25). As 
there is a lack of information relating to the antibody status versus 
PiCV genomic load in sera of healthy or affected PiCV naturally 
infected birds.  The aim of the present work is to produce a PiCV 
capsid which can be used to develop a specific, sensitive method 
for detecting antibodies to PiCV, and to develop the knowledge of 
the PiCV biology in applying this test to serum samples collected 
from symptomatic or asymptomatic pigeons whose viral load was 
measured by real time PCR. 
MATERIALS AND METHODS
Test Samples and DNA extraction
Samples were obtained from 28 racing pigeons derived from one loft 
containing 140 birds that had a five-year history of PiCV infections 
and YPDS. Samples were collected from  6 adult pigeons (Table 1, # 
1 to 6), 6 eight-month-old pigeons (Table 1, # 7 to 12) and 16 young 
pigeons aged 2 weeks to 4 months (Table 1, # 13 to 28), four of which 
presented with signs of YPDS (Table 1, # 20, 24, 25 and 27). Blood 
samples were collected by venipuncture of the medial metatarsal vein 
and sera were collected. The BF was collected from 15 pigeons (Table 
1, # 13, 15 - 28).  Viral DNA was extracted from BF and serum samples 
using the QIAmp DNA mini kit (Qiagen Benelux b. v., Venlo, The 
Netherlands) according to the manufacturer’s instructions. For serum, 
50 µl were used as starting material respectively, while about 50 mg 
tissues were homogenized for extraction. Extracted DNA’s were 
eluted in 100 µl buffer and stored at – 20° C until use.  Remaining 
tissue samples were fixed in 10% neutral buffered formalin. 
Formalin-fixed samples were dehydrated, embedded in paraffin 
wax and sectioned at 4 µm for examination by light microscopy. 
All sections were stained with hematoxylin and eosin (HE).
Pigeon Age BI PCR QPCRa PCR QPCRb log
2
 IIF titres 
N°             
          Sera         BF
1 5 y. NT neg neg NP NP 7
2 5 y. NT neg neg NP NP 6
3 5 y. NT neg neg NP NP 5
4 4 y. NT neg neg NP NP 6
5 3 y. NT neg neg NP NP 5
6 1 y. NT neg neg NP NP 5
7 8 m. NT P 1.5 x 102 NP NP 6
8 8 m. NT P 3.3 x 103 NP NP 8
9 8 m. NT P 1.5 x 102 NP NP 8
10 8 m. NT neg neg NP NP 7
11 8 m. NT neg neg NP NP 5
12 8 m. NT neg neg NP NP 8
13 4 m. X P 1.14 x 105 P 1.78 x 107 7
14 4 m. NT P 6.72 x 105 NT NT 5
15 3 m. neg P 2.66 x 104 P 4 x 108  6
16 3 m. neg P 4.26 x 105 P 5.83 x 109  4
17 3 m. neg P 3.59 x 104 P 8.5 x 109  7
18 2 m. X P 2.28 x 105 P 3.5 x 108  6
19 2 m. neg P 4.41 x 107 P 8.7 x 109  6
20* 2 m. XXX P 5.47 x 108 P 3.2 x 1010  8
21 6 w. neg P 2.66 x 105 P 2.78 x 106  7
22 5 w. neg P 3.26 x 105 P 6.34 x 105  6
23 5 w. XX P 4.51 x 108 P  3.79 x 1010  6
24* 4 w. XXX P 1.84 x 109 P 7.83 x 109  5
25* 4 w. XX P 3.51 x 107 P 9.6 x 1010  4
26 4 w. (X) P 4.32 x 105 P           1.13 x 1010  5
27* 4 w. XXX P 2.02 x 108 P           2.41 x 1010  neg
28 2 w. neg P 5.11 x 105 P 4 x 102  4









a: quantitative PCR, number
of genome copies per µl sera 
b: quantitative PCR, number
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Cells
Spodoptera frugiperda (Sf9) cells (Invitrogen, Merelbeke, 
Belgium) were used to propagate baculovirus and were 
cultured in Sf 900 medium (Gibco, Invitrogen, Merelbeke, 
Belgium) at 27° C. 
Production of PiCV ORF C1 structural gene
Primers 5’-GCC ACC ATG AGA AGG AGG AGA TTC 
CGC-3’ and 5’-TTC AGA ATC CAC AGC TGA GTC-3’ were 
designed for amplification of PiCV open reading frame   (ORF C1). 
ORF C1 (an 825 base pairs (bp) fragment) was amplified from the 
genome clone of PiCV isolate 9030 (accession number AJ298229). 
PCR was performed on a Biometra TGradient DNA thermal cycler 
(Westburg, Leusden, The Netherlands). An initial denaturation 
step of 10 min at 94 °C, was followed by 40 thermocycles each 
comprising 45 sec at 94 °C, 60 sec at 62 °C, 90 sec at 72 °C and 
a final elongation step for 10 min at 72 °C. The PCR amplicon 
was visualised by electrophoresis in 1.2 % agarose gel containing 
ethidium bromide under ultraviolet transillumination.
Molecular cloning and expression of PiCV ORF C1 protein
 The vector pBlueBac4.5/V5-His-Topo® (Invitrogen, 
Merelbeke, Belgium) was used as baculovirus transfer vector 
according to the manufacturer’s instruction and the recombinant 
vector was transformed into TOP10 Escherichia coli (Invitrogen, 
Merelbeke, Belgium). Ten colonies were analyzed by PCR with 
polyhedrin forward (5’-AAA TGA TAA CCA TCT CGC-3’) and 
V5 C-term reverse (5’-ACC GAG GAG AGG GTT AGG GAT-3’). 
An initial denaturation step (10 min at 94° C) was followed by 
30 thermocycles each comprising 60 sec at 94.0 ° C, 60 sec at 
55° C, 60 sec at 72.0° C and a final elongation step for 10 min at 
72.0° C. The PCR amplicon was visualised by electrophoresis in 
1.2 % agarose gel containing ethidium bromide under ultraviolet 
transillumination and a positive clone containing the gene of 
interest was selected.
The recombinant pBlueBac4.5/V5-His-Topo was 
transfected into Sf9 cells with Bac-N-BlueTM DNA in presence 
of Cellfectin® (Invitrogen, Merelbeke, Belgium) to generate 
a recombinant baculovirus expressing ORF C1 protein (Ac.
PiCVcap.ORF C1). Selection of the transfected baculovirus 
was performed by purification of recombinant virus by plaque 
assay. Sf9 cells that had been infected with virus dilutions were 
overlaid with Grace‘s insect medium containing agar (1%) and 
X-Gal (50 mg/ml). Blue plaques were selected and amplified. 
To verify the purity of the recombinant virus, viral DNA was 
extracted from the infected cells pellet with QIAmp® DNA Mini 
Kit (Qiagen, Benelux b. v., Venlo, The Netherlands) and PCR 
was performed with forward primer: 5’-TTT ACT GTT TTC 
GTA ACA GTT TTG-3’ and reverse primer: 5’-CAA CAA CGC 
ACA GAA TCT AGC-3’. An initial denaturation step (2 min at 
94° C) was followed by 30 thermocycles each comprising 1 
min at 94.0 ° C, 2 min at 55° C, 3 min at 72.0° C and a final 
elongation step for 7 min at 72.0° C. The PCR amplicon was 
visualised by electrophoresis in 1.2 % agarose gel containing 
ethidium bromide under ultraviolet transillumination.
Conventional PCR
Conventional PCR assays were performed using a protocol 
fully described previously (20). Briefly, the primer set (forward, 
5’- GCA TAA GGT GCC CGT GAA AGG-3’ ; reverse, 5’-
ATT CGC GGT CGC TCC GCT-3’) was used at 0.5 µM in 
50 µl reaction mixtures, each comprising 25 µl Taq Master 
Mix (Qiagen Taq PCR Master Mix Kit), 10 µl Q solution, 5 
µl forward primer, 5 µl reverse primer and 5 µl template. An 
initial denaturation step (2 min at 94° C) was followed by 45 
thermocycles each comprising 45 sec at 94.0 ° C, 60 sec at 
64.5° C, 60 sec at 72.0° C and a final elongation step for 7 
min at 72.0° C. The PCR amplicon (331 bp; nucleotides 787 to 
1117 within the sequence of the full PiCV genome clone 9030; 
accession number AJ298229) was visualised by electrophoresis 
in 2 % agarose gel containing ethidium bromide under 
ultraviolet transillumination. This amplicon encompassed the 
3’ terminus of the ORF V1 encoding the Rep and part of the 
3’ intergenic region of the PiCV genome. The PCR test was 
capable of detecting 4 attograms of target DNA. 
SYBR Green real time PCR
The SYBR green real time PCR was performed using a 
method which has been fully described elsewhere (23). Briefly, 
a primer set (forward YP09, 5’-GGT ACC CGC ATA AGG 
TGC CCG T-3’; reverse YP10 5’-TTG ATC CGC CGG AAG 
AGC GCC T-3’) was used and all amplification reactions were 
performed in a total volume of 25 µl using a mini Opticon (Bio-
Rad Laboratories, Nazareth, Belgium) with 48-microwell plates. 
Each well contained 2.5 µl of the extracted DNA sample or 
positive standard control, 12.5 µl of iQ SYBR® Green Supermix 
(Bio-Rad, Laboratories, Nazareth, Belgium), 2.5 µl of each 
diluted primer (2 µM) and 5 µl of distilled water. Samples with 
copy numbers greater than 108 were diluted in water so that they 
generated values within the standard curve.  The thermal profile 
consisted of a first step of denaturation of 95° C for 15 min and 45 
cycles of 3 steps: 95° C, 64.3° C and 72° C each for 30 sec. The 
melting curve was performed from 45° C to 95° C in 0.5° C/10 sec 
increments.  Each reaction was performed in duplicate. Absolute 
quantification of copies was carried out by comparing the cycle 
threshold (Ct) values obtained with the standard curve using 
the Thermal cycler software (Bio-Rad). Each analysis included 
a positive control (103 copies) and a blank control consisting of 
distilled water.  PCR efficiency (E) was calculated from standard 
curves using the following formula: % E = [10-1/slope-1] x 100 
that gives the percentage of template molecules that was doubled 
during each cycle. Only runs within the range 95-105 % and 
with a coefficient of determination (R2) > 0.98 were analysed.
Indirect immunofluorescence assay
Pigeon sera were diluted in two-fold increments starting at 
1:16 in PBS with 0.05% tween 20 containing 10 % calf serum.  Sf9 
cells were cultured in 24-well microtiter plates and monolayers 
were infected with the recombinant baculovirus Ac.PiCVcap.ORF 
C1.  For control purposes, sera were tested against both infected and 
untreated cells. After 3 days the overlaying medium was removed 
and cells rinsed with PBS. Then the cell monolayer was fixed with 
paraformaldehyde and permeabilization of cells was performed as 
described elsewhere (26). Subsequently, an immunofluorescent 
staining was performed. In brief, 150 µl of dilutions of the pigeon 
sera were added for 1 h at 37°C. After 3 washing steps, conjugated 
rabbit anti-pigeon Ig/FITC (Nordic Immunology, Tilburg, The 
Netherlands) were used as secondary conjugate. All analyses 
were made in duplicate.  Epifluorescence microscopy analysis 
was performed and the last dilution giving clear fluorescence was 
considered as the end titre.
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Figure 1: Western blotting analysis of PiCV ORF C1 protein 
expressed in insect cells Sf9. Lane M is a protein molecular 
weight marker standard. Total lysate of Sf9 cells infected with 
Ac.PiCVcap.ORF C1 (lane 1) or not infected (lane 2) was loaded.
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Western immunoblot analysis
The Sf9 cells infected with recombinant baculovirus (MOI 
5) were harvested 72 h post inoculation. Cells were washed twice 
with PBS and were lysed by freezing at – 80°C and thawing. Total 
proteins were separated on a 12 % SDS-PAGE (NuPAGE® Gel, 
Invitrogen, Merelbeke, Belgium), transferred onto a nitrocellulose 
membrane and identified with specific mouse monoclonal anti-
histidine antibody (Invitrogen, Merelbeke, Belgium) and a 
chemiluminescence peroxidase substrate kit (Sigma-Aldrich, 
Bornem, Belgium).
Statistical analysis
For the statistical analysis, data were transferred to 
Microsoft EXCEL, where the means, standard deviation were 
calculated. A permutation test was used to determine the statistical 
significance of the means. Differences were considered significant 
when p<0.05.
RESULTS
Expression of the PiCV ORF C1 protein
PiCV ORF C1 gene was successfully amplified, inserted 
into the baculovirus transfer vector pBlueBac4.5/V5-His-Topo® 
and by recombination with Bac-N-BlueTM baculovirus DNA 
resulted in the construct of a recombinant baculovirus expressing 
recombinant PiCV capsid protein in Sf9 insect cells harvested 72 
h post infection.  The western immunoblot analysis with mouse 
monoclonal anti-histidine antibody demonstrated the presence of a 
protein of approximately 30 kDA (Figure 1). This protein was not 
present in the control uninoculated insect cells.
Histological studies
Botryoid inclusion bodies were seen in macrophages of the 
BF of 8 pigeons (Table 1, # 13, 18, 20, 23, 24, 25, 26 and 27). 
BFs from 3 (Table 1, #: 20, 24 and 27) of the four sick pigeons 
contained the greatest number of inclusion bodies. No bursitis, 
necrosis or lymphoid depletion was observed. The BF of pigeon 
28 was noted to be smaller than for the age of the bird. 
Immunofluorescence assay
The results are presented in Table 1. With the exception of 
pigeon number 27, serum samples from all the birds were positive 
for antibodies to PiCV antigen present in insect cells infected 
with the recombinant baculovirus Ac.PiCVcap.ORF C1.  Indirect 
immunofluorescence (IIF) test log
2
 titers varied from 4 to 8 (Figure 
2). There were no significant differences between different age 
groups or between sick and healthy pigeons and pigeons with or 
without bursal inclusions. 
PCR and SYBR Green Real Time PCR assays
Results are presented in Table 1. All sera of adult pigeons (1 
year or older) were negative by the conventional and SYBR real 
time PCR assays. Among the 6 eight- month-old pigeons tested, 3 
birds (Table 1, # 7, 8 and 9,) were found positive both by PCR and 
real time PCR with weak viral loads (up to 3.3 x 103 copies per µl 
of serum). In contrast, a high viral load has been demonstrated in 
all the young pigeons in both sera (up to 1.84 x 109 copies genome/
µl) and bursa (up to 9.6 x 1010 copies genome/ milligram tissue) 
(Table 1, # 13 to 28).
Viral loads in the sera of sick young pigeons (Table 1, # 
20, 24, 25 and 27) were significantly higher when compared 
to those of clinically healthy ones (Table 1, # 13, 15, 16, 17, 
18, 19, 21, 22, 23, 26, 28) when results were submitted to a 
permutation test (10000 runs; p = 0.01).  Significant differences 
(permutation test; 10000 runs; p = 0,026) were also observed 
when the viral loads in sera of pigeons (Table 1, # 13, 18, 20, 
23, 24, 25, 26 and 27) with classical botryoid inclusions in BF 
were compared with the viral loads of pigeons (Table 1, # 15, 
16, 17, 19, 21, 22 and 28) without BF inclusions. 
BF viral loads in sick pigeons (Table 1, # 20, 24, 25 and 27) 
were significantly higher (permutation test (10000 runs;  p = 
0.015) when compared to the viral loads of clinically healthy 
pigeons (Table 1, # 13, 15, 16, 17, 18, 19, 21, 22, 23, 26, 28). 
Similarly the BF viral loads of pigeons (Table 1, # 13, 18, 20, 
23, 24, 25, 26 and 27) with bursal botryoid inclusions were 
significantly higher (permutation test; 10000 runs;  p= 0.017) 
than those of pigeons (Table 1, # 15, 16, 17, 19, 21, 22 and 28) 
without BF inclusions. 
Figure 2: Expression of PiCV capsid protein in Sf 9 cells fixed 
72 h post-infection and detected using an IIF assay with pigeon 
sera and rabbit anti-pigeon-FITC.
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DISCUSSION
To date, avian circoviruses have not been grown in cell 
culture and detection of specific antibodies has only been 
performed in a few cases.  An IIF assay that utilized goose 
circovirus capsid protein antigen produced within baby 
hamster kidney cells by the eukaryotic Semliki forest virus 
expression vector has been described for geese (27) and a 
hemagglutination inhibition assay was developed for psittacine 
beak and feather disease (PBFD) virus serum antibody (28). 
Baculovirus expression of PBFD virus capsid protein was a 
suitable replacement antigen for serological detection of the 
psittacine circovirus by hemagglutination inhibition assay 
(29). An indirect enzyme-linked immunosorbent assay for the 
detection of PiCV-specific serum antibody is now available. 
By testing 118 field sera collected in the years 1989, 1991, 
1994 and 2008, virus-specific antibody was detected in 75% 
of the sera, without correlation for the disease status of the 
birds (25). 
Serological tests for detecting virus-specific antibodies 
are important tools for the diagnosis of infection and 
epidemiological studies, and as in the present study, to 
investigate if there is a relationship between disease status 
and antibody levels. The IIF assay described here is a fast, 
specific and sensitive method for the detection and titration 
of circulating antibodies to PiCV in pigeon serum. In the 
present study, the antibody titers were relatively low; only 4 
pigeons out of 28 had a titre of 8 expressed in log
2
 IIF titres. 
One four-week-old pigeon (Table 1, # 27) presenting with the 
signs of YPDS was serologically negative. This could be due 
to early infection leading to immunotolerance or to the direct 
effect of the virus on the immune system, or it could be that 
maternal derived antibodies has waned, and the bird has not 
yet developed its own antibodies. The three other affected 
birds (Table 1, # 20, 24 and 25) had serum log
2
 titres between 
8 to 4. There was no significant difference between the titers in 
sick and clinically normal birds. This is in contrast to the findings 
in psittacine birds where a hemagglutination inhibition assay 
showed that antibody titers could not be detected in serum from 
42 PBFD-affected birds whereas serum titers from 64 normal 
psittacine birds ranged from less than log
2
 1 to log
2
 8 (29) and the 
observation that birds with active PBFD virus infections had lower 
antibody value than birds that had been exposed to the virus, but 
remained clinically normal (28).   For CAV, maternal antibodies 
provide complete protection of young chicks against the virus 
for approximately the first 3 weeks of life (31, 32). Although the 
adult pigeons have antibodies as measured by IIF, infection and 
the disease seem to reoccur in young pigeons annually. It may be 
that either maternally derived antibody to PiCV is not protective 
or that the majority of the young pigeons are infected in the 
rearing loft after 3 weeks of age (12). In this scenario, it may be 
relevant that the primary effect of CAV is depletion of the T cells 
in the thymus with minimal effect on the B cells in the BF, while 
PiCV appears to deplete both the B and T cells populations which 
may impair severely the ability to mount an antibody response. 
This difference may influence the pathogenesis (16).  
These preliminary results suggest that the antibodies 
measured by IIF play a minor role as far as infection and 
disease expression are concerned or possibly that some young 
birds do not have the time or ability to develop a suitable 
antibody response.
The present study also describes the quantification of viral 
load by real time PCR, in samples of serum and BF collected 
from clinically healthy or naturally affected pigeons. The 
results show that in sick pigeons viral load is significantly 
higher in BF and serum than in clinically healthy pigeons. 
This suggests that the detection of high levels of virus could 
be associated with the clinical status of the birds.
In pigs, PMWS is associated with PCV2 infection. 
In this species, the capsid protein was found to be a major 
immunogen able to protect pigs against a PCV2 challenge 
(33). A recombinant PBFD virus capsid protein assessed as 
a vaccine for psittacine beak and feather disease protected 
vaccinated birds from feather lesions and, reduced viral 
replication in vaccinated birds compared with non-vaccinated 
control birds (34). Thus the capsid protein of PiCV expressed 
by recombinant baculovirus in insect cells could be considered 
as a potential vaccine candidate in three week-old unprotected 
pigeons and for vaccination before mating to increase maternal 
derived antibody levels. 
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